<DOC>
	<DOCNO>NCT02808299</DOCNO>
	<brief_summary>The purpose study investigate incidence liver injury statin coronary heart disease ( CHD ) patient history hepatitis B virus ( HBV ) infection .</brief_summary>
	<brief_title>Liver Injury Statins Patients With History Hepatitis B Virus Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Encephalitis , Herpes Simplex</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>patient CHD receive longterm statin treatment ALT ULN baseline infection Hepatitis A Virus , Hepatitis C Virus Hepatitis E Virus triglyceride 4.5 mmol/L decompensated liver cirrhosis ( Child B C ) active stage HBV infection Burkitt 's lymphoma virus cytomegalovirus , acute infectious disease congestive heart failure malignant tumor autoimmune disease receive potential hepatotoxicity drug immunosuppressant , antituberculotic nonsteroid antiinflammatory drug .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>statin</keyword>
	<keyword>hepatitis B virus</keyword>
</DOC>